|
MSL3L2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.385600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.970600E-01 |
| Normal-vs-Stage2 |
7.169400E-01 |
| Normal-vs-Stage3 |
5.955600E-03 |
| Normal-vs-Stage4 |
1.182310E-03 |
| Stage1-vs-Stage2 |
4.199400E-01 |
| Stage1-vs-Stage3 |
4.06310000000687E-05 |
| Stage1-vs-Stage4 |
9.54439999999446E-05 |
| Stage2-vs-Stage3 |
9.731500E-02 |
| Stage2-vs-Stage4 |
5.161700E-02 |
| Stage3-vs-Stage4 |
4.956600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.998000E-01 |
| Normal-vs-AfricanAmerican |
2.858600E-03 |
| Normal-vs-Asian |
3.146200E-01 |
| Caucasian-vs-AfricanAmerican |
3.661300E-03 |
| Caucasian-vs-Asian |
6.951200E-01 |
| AfricanAmerican-vs-Asian |
6.184000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.444600E-01 |
| Normal-vs-Female |
9.653800E-02 |
| Male-vs-Female |
1.293560E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.056590E-01 |
| Normal-vs-Age(41-60Yrs) |
5.602000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.756070E-03 |
| Normal-vs-Age(81-100Yrs) |
6.848800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.57960000000324E-05 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.59239999759131E-08 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.935800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.462200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.356800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.310200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.939500E-03 |
| Classical-VS-Follicular |
2.799700E-02 |
| Classical-VS-Other |
2.788000E-01 |
| Classical-VS-Normal |
2.203200E-01 |
| Tall-VS-Follicular |
1.027780E-04 |
| Tall-VS-Other |
1.114210E-01 |
| Tall-VS-Normal |
2.103400E-03 |
| Follicular-VS-Other |
5.159000E-01 |
| Follicular-VS-Normal |
3.143000E-01 |
| Other-VS-Normal |
4.068600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.892600E-01 |
| Normal-vs-N1 |
6.174200E-02 |
| N0-vs-N1 |
4.169800E-02 |
|
|
